Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

265 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Insurtech Collaboration Between Insurers And Healthcare Providers Will Transform The Healthcare Expe

    Insurtech is thriving – evidenced by the $8.5 billion insurtech investment raised in the last five years. But as the insurtech market becomes more saturated,
    ChinaInsurance
    Clyde & Co
    Clyde & Co
  • Article

    Beijing Intellectual Property Court Releases 2025 Annual Case List

    On April 21, 2026, the Beijing Intellectual Property Court published its annual case list for 2025. The release includes ten main cases (available in both Chinese and English) and nine nominated cases.
    ChinaIntellectual Property
    AFD China
    AFD China
Article

CTMO Released Notice to Open Trademark Registration in Retail and Wholesale Service in China

All of the pharmaceutical companies, especially those with business in China, should register their trademarks in China.
ChinaIntellectual Property
King & Wood Mallesons
King & Wood Mallesons
  • Article

    CBIRC Issues Newly-Revised Health Insurance Regulations

    On 12 November 2019, China's Banking & Insurance Regulatory Commission ("CBIRC") published its newly-revised Health Insurance Regulations ("Revised Regulations")
    ChinaFood, Drugs, Healthcare, Life Sciences
    Clyde & Co
    Clyde & Co
  • Article

    China Introduces New Medical Device GMP And GSP Rules

    The CFDA expects all device companies to comply with the New GMP and GSP rules as long as they intend to sell the products in China.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China Issues Guidance Clarifying Core Tasks And Deadlines For Application Of The Country's Telemedicine System

    These developments present significant opportunities for foreign health care providers and other investors.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    RDPAC Code of Practice 2012

    The new code has further refined and defined the relevant requirements and standards for medical promotion.
    ChinaFood, Drugs, Healthcare, Life Sciences
    King & Wood Mallesons
    King & Wood Mallesons
  • Article

    National Network For Medical Insurance Settlement

    An executive meeting of the State Council, China's Cabinet, on Wednesday, decided to further deepen healthcare reform.
    ChinaInsurance
    AnJie Broad Law Firm
    AnJie Broad Law Firm
  • Article

    Pharmaceutical/Cosmetic/Beverage Industries: New Cap On Pre-Tax Deductible Ad Fees

    A new tax circular relating to the increase of the cap on deductible advertisement and promotion fees in China’s pharmaceutical, cosmetic and beverage industries.was introduced on 31 July 2009 (“Circular”).
    ChinaTax
    CMS Cameron McKenna Nabarro Olswang
    CMS Cameron McKenna Nabarro Olswang
  • Article

    WIPO世界知的財産グローバル賞、中国企業6社が最終候補入り

    世界知的所有権機関(WIPO)が2026年のWIPOグローバルアワードの最終候補33社を発表し、中国企業6社が選出されて国別で最多となった。環境、健康、情&
    ChinaIntellectual Property
    Kangxin
    Kangxin
  • Article

    Compliance - watchword of healthcare companies and possibly other companies in China

    Chinese actions against a British pharmaceutical company have been a cover story for domestic and international media.
    ChinaCorporate/Commercial Law
    King & Wood Mallesons
    King & Wood Mallesons
  • Article

    Chinese Coronavirus Outbreak – What Employers Need To Know

    The Centers for Disease Control and Prevention (CDC) has indicated that it is closely monitoring an outbreak caused by a new 2019 Novel Coronavirus...
    ChinaEmployment and HR
    Seyfarth Shaw LLP
    Seyfarth Shaw LLP
  • Article

    China's State Council Announces Major Policies to Reform the Pharmaceutical Industry

    China will launch further reforms in the pharmaceutical sector as part of the healthcare reform initiatives announced by the State Council in its February 9, 2017 Circular on Several Opinions Concerning Further Reforms of the Policies Governing Drug Production, Circulation and Usage (the "Circular No.13").
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    House Members Send Letters To FBI, NIH Directors On Possible Racial Profiling Of Chinese Scientists

    Over the past few years, as the federal government has firmed its stance against intellectual property theft and foreign interference in scientific research, many in the U.S. research community have perceived a growing threat to scientific inquiry.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    State Food And Drug Administration ("SFDA") - Enhancing Supervision Of Internet Pharmaceutical Trading Activities

    On 8 January 2013, SFDA released a report concerning the results of its continuing investigations into online pharmaceutical trading activities conducted pursuant to their notice issued by them on 24 February 2012.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Clyde & Co
    Clyde & Co
  • Article

    State Food And Drug Administration ("SFDA") — 俄 Enhancing Supervision Of Internet Pharmaceutical Trading Activities

    A discussion on the investigations relating to the ever-increasing online sale of pharmaceuticals in China.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Clyde & Co
    Clyde & Co
  • Article

    China Liberalizes Drug Pricing Control

    Beginning June 1, 2015, the vast majority drugs in China, except for narcotic and Type 1 psychotropic drugs, will be free from government-set pricing.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China Advances Pharmaceutical Data Protection Regime With New Draft Measures

    On March 19, 2025, China's National Medical Products Administration (NMPA) released the Draft Measures for the Protection of Drug Trial Data...
    ChinaFood, Drugs, Healthcare, Life Sciences
    A&O Shearman
    A&O Shearman
  • Article

    China Expands Telemedicine Programs To Provinces

    Telemedicine continues to attract international attention, with China on track to become one of the largest telemedicine markets in the world.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    China Telemedicine Tackles Long Term Care: Business Opportunities And Government Guidance

    This post is the fifth in Foley’s blog series, "Realizing the Potential of Telemedicine in China," meant to address top issues facing U.S. companies looking to enter the Chinese telemedicine market.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Showing 21–40 of 265 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics